Next‐generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy
Richard J. Cassidy(Florida Cancer Specialists & Research Institute), Kristin Higgins(Emory University), Joseph W. Shelton(Emory University), Gabriel Sica(Emory University), Pretesh Patel(Emory University), Walter J. Curran(Piedmont Cancer Institute), Charles E. Hill(Emory University), Michael R. Rossi(Sema4 (United States)), C. Escott(Emory University), Seth Force(Emory Healthcare), Félix G. Fernández(Emory University), Conor Steuer(Emory University), Suresh S. Ramalingam(Emory University), Xinyan Zhang(Emory University), Madhusmita Behera(National Institutes of Health), Rathi N. Pillai(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center)
Cited by 41
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k